Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Explore the retirement accounts that yield the highest returns. Make informed decisions to grow your retirement savings effectively.
25,180 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Federal health officials issued a warning about misleading statements from biotech billionaire Patrick Soon-Shiong re...
A sweeping defense modernization plan totaling $185 billion could lift software-focused players like Palantir as miss...
Marathon Digital climbs as Bitcoin slides, buoyed by a strategic pivot into enterprise AI compute infrastructure and ...
A Middle East conflict could lift oil prices and boost inflation in the United States, prompting fresh debates about ...
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
Argan stock ascended today as investors cheered stronger profits and a brighter outlook for energy infrastructure tie...
Gold and silver surged as hopes for a US–Iran deal cooled inflation pressures and a softer dollar sparked a shift int...
A robot rollout tied to Melania Trump ignites a national debate over funding and the future of public schools. The te...
Salesforce faces leadership questions as founder Marc Benioff approaches three decades at the helm. The company is st...
Rocket Lab faces a pivotal Q1 print this evening as analysts weigh Neutron timing against a record backlog. Guidance ...
The White House is pushing to repaint a nearby historic building, a move critics say would hurt the structure and dra...